DOTmed July 22, 2024
HealthCare Business News sat down with Shyam Natarajan, CEO of Avenda Health, to talk about the evolution of prostate cancer AI, and how new breakthroughs are opening the doors to better treatment outcomes for patients
HCB News: What are some specific ways in which in-clinic AI imaging platforms can improve access to prostate cancer screening and treatment for patients?
Shyam Natarajan: In-clinic AI imaging platforms hold immense potential to democratize care and reduce healthcare disparities in prostate cancer screening and treatment. By providing highly accurate and consistent imaging analysis, AI ensures that patients receive the same level of diagnostic precision whether they are in a major metropolitan hospital or a rural clinic. AI systems can assist novice practitioners in underserved...
Today's Sponsors
Today's Sponsor